GlassScriptPhysician profile
Carlos A Leon
NPI 1982694030
$3,611.50
in general payments reported to CMS, 2019-2025
21 companies · $496 in 2025
The $496 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $458 · 2020: $46.44 · 2021: $516 · 2022: $1,438 · 2023: $413 · 2024: $244 · 2025: $496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,152.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,207.55 | 2019-2025 | |
| Heartflow, INC. | $768.21 | 2022 | |
| Abiomed | $294.79 | 2021-2023 | Impella |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $274.09 | 2019-2024 | Xifaxan |
| Boston Scientific Corporation | $241.27 | 2022-2025 | Watchman Access System, General - Polypectomy |
| Gilead Sciences, INC. | $121.15 | 2021-2023 | |
| Janssen Biotech, INC. | $109.57 | 2019-2024 | Stelara, Tremfya |
| Genzyme Corporation | $94.43 | 2025 | |
| Exact Sciences Corporation | $90.63 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Celgene Corporation | $74.33 | 2022-2024 | Zeposia |
| Romark Laboratories, Lc | $62.49 | 2019 | |
| Ironwood Pharmaceuticals, INC | $47.05 | 2020-2023 | Linzess |
| Takeda Pharmaceuticals U.S.A., INC. | $44.12 | 2021-2022 | |
| Conmed Corporation | $30.12 | 2021 | |
| Ardelyx, INC. | $28.40 | 2024 | Ibsrela |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $28.07 | 2025 | |
| Redhill Biopharma INC. | $24.77 | 2021 | |
| Intercept Pharmaceuticals, INC. | $20.74 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $20.33 | 2022 | |
| Shionogi INC | $16.05 | 2019 | |
| Allergan, INC. | $13.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlos Leon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.